Cotton Mouton Diagnostics Ltd (CMD), a Cardiff based diagnostics company, has developed a rapid and novel point-of-need analytical platform based on proprietary intellectual property. This technology has initially been applied to the rapid and sensitive detection of bacterial endotoxins in the large and expanding pharmaceutical quality control market.
CMD have also developed several clinical assays on the platform, detecting biomarkers of interest in a matter of minutes. The technology is readily applicable to pre-hospital care, an under-utilised area of medical diagnostics, where for many clinical conditions rapid-diagnosis and treatment is critical if favourable patient outcomes are to be delivered.
CMDs technology is protected by a comprehensive IP portfolio, with three patent families granted across multiple territories.